Renal cancer metastatic – Life with Disease

Go back

Metastatic renal cell carcinoma represents an advanced stage of kidney cancer where the disease has spread beyond the kidney to other parts of the body, such as the lungs, bones, brain, or liver. While this stage cannot typically be cured, modern treatments can help control the cancer’s growth, relieve symptoms, and extend life expectancy, allowing many people to manage their condition and maintain quality of life for extended periods.

Understanding Your Prognosis

When kidney cancer spreads to other parts of the body, it becomes what doctors call metastatic renal cell carcinoma, or stage IV kidney cancer. Learning about your prognosis means understanding what doctors expect regarding how the disease might progress and how long you might live with this condition. These are naturally difficult conversations, but having realistic information can help you and your family plan and make informed decisions about your care.[1]

The outlook for metastatic kidney cancer varies greatly from person to person. When kidney cancer has spread to distant organs, the five-year survival rate is approximately 12 percent, meaning that about 12 out of every 100 people with this diagnosis are alive five years after their diagnosis. However, these statistics represent averages across all patients and don’t predict any individual person’s outcome. Many factors influence prognosis, including where the cancer has spread, how quickly it’s growing, your overall health, and how well you respond to treatment.[11]

Medical teams use a system called the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) criteria to estimate prognosis. This system looks at six specific factors: how quickly the cancer developed after diagnosis, your performance status (how well you can carry out daily activities), and levels of certain substances in your blood including hemoglobin, calcium, neutrophils, and platelets. Based on these factors, patients are classified into favorable-risk, intermediate-risk, or poor-risk groups. People in the favorable-risk group have a median overall survival of about 43 months, intermediate-risk patients about 22.5 months, and poor-risk patients about 7.8 months. These numbers help doctors recommend appropriate treatments, but individual outcomes can differ significantly.[7]

It’s important to understand that while metastatic kidney cancer typically cannot be cured, it is not always rapidly fatal. Some people experience what doctors call an “indolent” course, meaning the cancer grows slowly and can be managed for several years. Additionally, treatment options have improved dramatically in recent years, particularly with newer immunotherapy drugs and targeted therapies. These medications have helped many people live longer and with better quality of life than was possible even a decade ago.[8]

⚠️ Important
Statistics about survival are based on large groups of people and represent averages. Your individual prognosis depends on many personal factors that make your situation unique. Some people live much longer than statistics suggest, especially with newer treatments. Talk openly with your healthcare team about your specific situation rather than relying solely on general statistics.

How the Disease Progresses Without Treatment

Understanding what happens if metastatic renal cell carcinoma goes untreated helps explain why doctors recommend treatment even when cure isn’t possible. As kidney cancer grows in its original location, it spreads into the fatty tissue and major blood vessels around the kidney. It may also creep into the adrenal gland, a small organ that sits right on top of the kidney and produces important hormones.[1]

From the kidney area, cancer cells can travel to other parts of your body through two main pathways. First, cancer cells can enter blood vessels and travel through your bloodstream, eventually settling in distant organs. Second, they can enter your lymphatic system, a network of vessels and nodes throughout your body that helps fight disease. Once cancer cells reach lymph nodes, they can spread even more widely. The most common places where kidney cancer spreads are the lungs and bones, but it can also travel to the brain, liver, ovaries, or testicles. In fact, medical reports document that this type of cancer has the capacity to appear almost anywhere in the body.[2][5]

One particularly challenging aspect of kidney cancer is that it often has no symptoms in its early stages. This means the cancer can spread before anyone even knows it’s there. By the time symptoms appear, the disease has often already reached stage IV. Approximately 33 percent of people with kidney cancer develop metastatic spread. About 20 to 50 percent of patients who had their kidney tumor removed will later develop metastases at some interval after surgery, meaning the cancer returns in distant locations.[5]

Without treatment, the growing tumors in various organs would continue to enlarge and interfere with normal body functions. Tumors in the lungs can make breathing increasingly difficult. Cancer in bones causes severe pain and can lead to fractures. Brain metastases can cause headaches, seizures, or changes in thinking and behavior. Liver involvement can affect the body’s ability to process nutrients and toxins. As the disease progresses, people typically experience worsening fatigue, significant weight loss, and increasing pain.[1]

Potential Complications to Watch For

Metastatic renal cell carcinoma can cause various complications, both from the cancer itself and from its effects on different body systems. Being aware of these potential problems helps you and your healthcare team address them quickly if they occur.

When cancer spreads to the bones, it can weaken them significantly, creating what doctors call pathological fractures—breaks that occur with minimal or no trauma because the bone has been weakened by cancer. Bone metastases also cause severe pain that may require specific treatments beyond standard pain medications. Some people develop elevated calcium levels in their blood (called hypercalcemia) when cancer affects bones, which can cause confusion, nausea, extreme thirst, and potentially dangerous heart rhythm problems.[1]

Lung metastases can lead to persistent coughing, shortness of breath, and accumulation of fluid around the lungs. This fluid buildup, called pleural effusion, can make breathing quite difficult and may require drainage procedures. Some people develop blood clots in their legs (deep vein thrombosis) or lungs (pulmonary embolism), which are serious complications requiring immediate medical attention.

Brain metastases present their own set of complications. Depending on where tumors develop in the brain, people may experience seizures, severe headaches, vision problems, difficulty with balance or coordination, personality changes, or confusion. These symptoms require prompt evaluation and treatment, which may include radiation therapy specifically directed at brain tumors.[4]

Kidney function can decline, particularly if both kidneys are affected or if the remaining kidney after surgery isn’t working optimally. When kidney function decreases significantly, waste products build up in the blood, potentially requiring dialysis. This also affects what foods you can eat and how much fluid you should drink.[15]

Many people with metastatic cancer develop significant fatigue that goes beyond normal tiredness. This cancer-related fatigue can be overwhelming and doesn’t improve with rest. It may result from the cancer itself, treatments, anemia (low red blood cell counts), poor nutrition, or emotional distress. Weight loss often becomes a concern, not just from loss of appetite but also from the cancer’s effects on metabolism. Some people develop night sweats so severe they need to change clothes or sheets during the night.[1]

Impact on Daily Life and Activities

Living with metastatic renal cell carcinoma affects virtually every aspect of daily life—physical abilities, emotional wellbeing, relationships, work, and leisure activities. Understanding these impacts helps you prepare and find ways to maintain the best possible quality of life.

Physically, the combination of cancer symptoms and treatment side effects can be exhausting. Many people describe feeling like their energy has been completely drained away. Simple tasks that once seemed effortless—cooking a meal, taking a shower, or walking up stairs—may leave you feeling wiped out. This profound tiredness, called fatigue, is one of the most common and frustrating symptoms. Pacing yourself becomes essential. You might need to save your energy for the activities that matter most to you and let go of others. Planning rest periods throughout the day isn’t a sign of weakness; it’s a practical strategy for managing your energy.[1][17]

Pain is another significant physical challenge. Whether from the original tumor site, metastases in bones or other organs, or as a side effect of treatments, pain can interfere with sleep, mobility, and overall comfort. Working closely with your healthcare team to manage pain is crucial. Many different medications and techniques are available, and you shouldn’t hesitate to speak up if pain isn’t well controlled. Some people find that complementary approaches like massage, meditation, or acupuncture help alongside medical treatments.[18]

Emotionally, a diagnosis of metastatic cancer is deeply distressing. Fear, anxiety, sadness, and anger are all normal responses. You might feel anxious about the future, treatments, or how your condition will affect loved ones. Some people experience anticipatory grief, mourning losses before they occur. Depression is common and is not a sign of weakness or giving up—it’s a medical condition that deserves treatment just like physical symptoms. Mental health support, whether through counseling, support groups, or medication when needed, is an important part of comprehensive cancer care.[14]

Relationships often become more complex. Family dynamics may shift as loved ones take on caregiving roles. Some people find that their illness brings them closer to family and friends, while others experience isolation or feel like a burden. Communication becomes both more important and more difficult. Talking about fears, needs, and preferences with loved ones takes courage but can strengthen connections. At the same time, some relationships may become strained, particularly if people don’t know how to help or are dealing with their own fears about your illness.[16]

Work life requires careful consideration. Some people continue working during treatment because it provides structure, purpose, and social connections. Others need to reduce hours, take medical leave, or stop working entirely. Financial concerns often accompany these decisions, adding another layer of stress. It’s worth exploring what workplace accommodations, disability benefits, or financial assistance programs might be available to you.

Exercise and physical activity, even in small amounts, can actually improve energy levels and mood, though this might seem counterintuitive when you’re feeling exhausted. Your doctor or a physical therapist can help you determine what’s safe and appropriate for your situation. Even gentle walking, stretching, or chair exercises can make a difference. Listen to your body and don’t push beyond what feels manageable.[18]

Diet and eating may become challenging due to changes in appetite, taste alterations from treatment, or nausea. Some people lose weight unintentionally, while managing any dietary restrictions needed for kidney function adds another layer of complexity. A registered dietitian who specializes in cancer care can provide personalized guidance to help you maintain nutrition and strength.[15]

Social activities and hobbies might need modification but shouldn’t necessarily stop. Finding ways to continue doing things you enjoy, even in adapted forms, helps maintain quality of life. Perhaps you can’t garden as vigorously but can still tend container plants. Maybe attending full concerts is too tiring, but you can listen to music at home. Staying connected to sources of joy matters tremendously.[17]

⚠️ Important
Self-care during cancer treatment isn’t selfish—it’s essential. This means prioritizing rest when needed, accepting help from others, communicating openly with your healthcare team about symptoms, and making time for activities that bring comfort or joy. Many people feel they should “tough it out” or not complain, but speaking up about difficulties allows your care team to provide better support.

Supporting Family Members Through Your Diagnosis

When you have metastatic renal cell carcinoma, your family members and close friends are also profoundly affected. They want to help but may not know how, and they’re dealing with their own fears and emotions about your illness. Understanding what family members need to know—particularly about clinical trials and research opportunities—can help them provide meaningful support.

First, family members should understand that clinical trials represent an important treatment option for metastatic kidney cancer. Clinical trials are research studies that test new treatments or combinations of treatments to see if they work better than current standard options. Contrary to some misconceptions, participating in a clinical trial doesn’t mean receiving inferior care or being used as a “guinea pig.” In fact, clinical trials often provide access to the newest and potentially most effective treatments before they become widely available. Participants receive careful monitoring and close attention from research teams.[6]

Families can help by researching what clinical trials might be available for your specific situation. Resources like the Kidney Cancer Association’s Clinical Trials Finder or the National Cancer Institute’s clinical trials database allow searching by cancer type, stage, and location. This research takes time and attention that you might not have the energy for, so family members taking on this task can be extremely helpful. They can compile information about potentially relevant trials, including what phase of research they’re in, what treatments they involve, where they’re conducted, and what the eligibility requirements are.[6]

When considering clinical trials, families should understand key questions to ask: What is the purpose of this trial? What treatments or procedures are involved? What are the possible benefits and risks? How might this trial affect daily life? What costs will insurance cover, and what might require out-of-pocket payment? Are there travel requirements? What happens if the treatment doesn’t work or causes serious side effects? Having family members present during these discussions provides extra ears to hear information and extra minds to think through decisions.

Beyond clinical trials, families provide crucial practical support. This might include accompanying you to appointments, taking notes during medical consultations, helping manage medications, assisting with daily tasks when fatigue is overwhelming, or coordinating with other family members and friends who want to help. Sometimes the most valuable support is simply being present—sitting with you during treatment, listening when you need to talk, or respecting when you need quiet.[14]

Family members need to care for their own emotional health too. Watching someone you love battle cancer is heartbreaking and exhausting. Caregivers often neglect their own needs, leading to burnout. Encouraging family members to seek their own support—whether through caregiver support groups, counseling, or taking breaks for self-care—ultimately benefits everyone. Some families find that counseling together helps improve communication and reduces the sense of isolation that both patients and caregivers often feel.

Open communication within families, while difficult, makes a significant difference. This includes talking about practical matters like advance care planning, what kind of care you would want if you become unable to make decisions, and how you want to spend your time. These conversations are painful but prevent confusion and conflict later when decisions must be made quickly. Some families find it helpful to include a spiritual advisor, social worker, or counselor in these discussions.[14]

Finally, families should know that support resources exist beyond just medical care. Social workers at cancer centers can help connect families with transportation services, financial assistance programs, home care services, support groups, and community resources. The Kidney Cancer Association and similar organizations offer education, support networks, and practical resources specifically for kidney cancer patients and their families. Taking advantage of these resources doesn’t mean you’re weak—it means you’re being smart about accessing available help.[16]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of metastatic renal cell carcinoma, based on the provided sources:

  • Sunitinib (Sutent) – A targeted therapy drug that works on VEGF proteins to stop tumor blood vessel growth, commonly used as first-line treatment
  • Pazopanib (Votrient) – A targeted therapy that inhibits vascular endothelial growth factor to limit cancer growth and spread
  • Sorafenib (Nexavar) – A VEGF-targeting medication that helps block signals that tell cancer cells to grow
  • Cabozantinib (Cabometyx) – A targeted therapy drug that works on VEGF pathways to control metastatic kidney cancer
  • Axitinib (Inlyta) – A targeted therapy medication that inhibits vascular endothelial growth factor receptors
  • Temsirolimus (Torisel) – A targeted therapy that works on mTOR protein to help control cell growth and division
  • Everolimus (Afinitor) – An mTOR inhibitor used to slow cancer cell growth and new blood vessel formation
  • Lenvatinib (Lenvima) – A tyrosine kinase inhibitor that may be used in combination with everolimus after VEGF therapy
  • Nivolumab (Opdivo) – An immunotherapy checkpoint inhibitor that helps the immune system recognize and attack cancer cells
  • Ipilimumab (Yervoy) – A CTLA-4 checkpoint inhibitor immunotherapy, often used in combination with nivolumab
  • Pembrolizumab – A PD-1 checkpoint inhibitor immunotherapy that may be used in combination with axitinib
  • Avelumab (Bavencio) – A PD-L1 checkpoint inhibitor immunotherapy approved for advanced kidney cancer
  • Bevacizumab (Avastin) – A monoclonal antibody that targets VEGF to inhibit tumor blood vessel growth
  • Aldesleukin (Proleukin) – A cytokine immunotherapy that targets the IL-2 pathway for advanced kidney cancer

Ongoing Clinical Trials on Renal cancer metastatic

  • Study on the Effectiveness of Atezolizumab with Radiotherapy for Patients with Metastatic Colorectal, Lung, Renal, and Sarcoma Cancers

    Recruiting

    1 1 1
    Investigated drugs:
    France

References

https://www.webmd.com/cancer/metastatic-renal-cell-carcinoma

https://www.healthline.com/health/metastatic-renal-cell-carcinoma

https://www.cancer.gov/types/kidney/patient/kidney-treatment-pdq

https://www.cancerresearchuk.org/about-cancer/kidney-cancer/advanced

https://pubmed.ncbi.nlm.nih.gov/12941198/

https://www.kidneycancer.org/diagnosis-treatment/diagnosis-and-staging/

https://www.ncbi.nlm.nih.gov/books/NBK566712/

https://www.cancer.gov/types/kidney/hp/kidney-treatment-pdq

https://www.cancerresearchuk.org/about-cancer/kidney-cancer/advanced

https://www.cancer.org/cancer/types/kidney-cancer/treating/by-stage.html

https://www.cancerresearch.org/immunotherapy-by-cancer-type/kidney-cancer

https://www.webmd.com/cancer/metastatic-renal-cell-treatments

https://cancer.ca/en/cancer-information/cancer-types/kidney/treatment/stage-4

https://www.cancerresearchuk.org/about-cancer/kidney-cancer/advanced/living

https://www.webmd.com/cancer/renal-cell-lifestyle-changes

https://www.kidneycancer.org/i-have-stage-iv-renal-cell-carcinoma/

https://www.mykidneycancerteam.com/resources/quality-of-life-with-renal-cell-carcinoma-tips-for-living-well

https://www.healthline.com/health/rcc/7-tips-to-improve-day-to-day-life-with-renal-cell-carcinoma

FAQ

Can metastatic kidney cancer ever be cured?

When kidney cancer has spread to distant organs, it typically cannot be cured with current treatments. However, treatments can often control the cancer for extended periods and help people live longer with better quality of life. In some rare cases, surgical removal of all known tumor sites has led to prolonged disease-free survival.

What are the most common places kidney cancer spreads to?

The most common sites where kidney cancer spreads are the lungs and bones. However, it can also travel to the brain, liver, adrenal glands, and other organs. More than one organ system is often involved in the metastatic process, and approximately 33 percent of people with kidney cancer develop metastatic spread.

How is metastatic kidney cancer different from early-stage kidney cancer?

Metastatic kidney cancer (stage IV) means the disease has spread beyond the kidney to lymph nodes or distant organs like the lungs, bones, or brain. Early-stage kidney cancer is still localized to the kidney or immediately surrounding tissue and can often be cured with surgery. The treatment approach and prognosis differ significantly between early and metastatic stages.

Will I need to have my kidney removed if cancer has already spread?

Sometimes doctors recommend removing the affected kidney (called cytoreductive nephrectomy) even when cancer has spread, as this may improve how well you respond to other treatments like targeted therapy or immunotherapy. However, the decision depends on many factors including where the cancer has spread, how much, and your overall health. Your medical team will discuss whether surgery makes sense for your specific situation.

What is the IMDC risk classification and why does it matter?

The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) classification uses six criteria including time to treatment, performance status, and blood test results to classify patients into favorable-risk, intermediate-risk, or poor-risk groups. This classification helps doctors estimate prognosis and select the most appropriate treatments, and it determines eligibility for certain treatment combinations.

🎯 Key takeaways

  • Metastatic kidney cancer cannot typically be cured, but modern treatments including immunotherapy and targeted therapy can control the disease for months or years while maintaining quality of life
  • About 33 percent of people with kidney cancer develop metastatic spread, with cancer most commonly traveling to the lungs and bones
  • The IMDC risk classification system helps predict outcomes and guide treatment decisions based on six specific criteria including blood test results and performance status
  • Kidney cancer is unusual because it rarely causes symptoms in early stages, often spreading before it’s detected
  • Clinical trials provide access to the newest treatments and represent an important option that families can help research and discuss with the medical team
  • Managing symptoms through open communication with healthcare providers significantly improves quality of life during treatment
  • Even light physical activity and good nutrition can help maintain strength and energy during treatment, despite seeming counterintuitive when fatigued
  • Emotional and mental health support is as important as physical treatment, with counseling and support groups providing valuable help for both patients and family members